ADIPOQ and cancer: Thus, with no reliable external control available (including endogenously induced or exogenously added full-sized adiponectin protein), we had to compare the activity of the new derivatives to the base peptide ADP355 (355), very heavily studied for its in vitro and in vivo functions earlier (Otvos et al., 2011a; Pepping et al., 2014), in cancer cell lines whose easily measurable proliferation properties were repeatedly shown to be characteristic to typical adiponectin functions (Jarde et al., 2009; Ozturk et al., 2012).